The maze of treatments for hepatitis B

被引：69

作者：

Lok, AS ^{[1
]}

机构：

[1] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI 48109 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 26期

关键词：

D O I：

10.1056/NEJMe058119

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2743 / 2746

页数：4

共 15 条

[1] A randomized, controlled trial of combination therapy for chronic hepatitis B:: Comparing pegylated interferon-α2b and lamivudine with lamivudine alone [J].

Chan, HLY ;

Leung, NWY ;

Hui, AY ;

Wong, VWS ;

Liew, CT ;

Chim, AML ;

Chan, FKL ;

Hung, LCT ;

Lee, YT ;

Tam, JSL ;

Lam, CWK ;

Sung, JJY .

ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :240-250

[2] EASL International Concensus Conference on Hepatitis B -: 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version) [J].

de Franchis, R ;

Hadengue, A ;

Lau, G ;

Lavanchy, D ;

Lok, A ;

McIntyre, N ;

Mele, A ;

Paumgartner, G ;

Pietrangelo, A ;

Rodés, J ;

Rosenberg, W ;

Valla, D .

JOURNAL OF HEPATOLOGY, 2003, 39 :S3-S25

[3]

Entecavir Review Team, 2005, 21797 NDA ENT REV TE

[4] Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy [J].

Fontana, RJ ;

Hann, HWL ;

Perrillo, RP ;

Vierling, JM ;

Wright, T ;

Rakela, J ;

Anschuetz, G ;

Davis, R ;

Gardner, SD ;

Brown, NA .

GASTROENTEROLOGY, 2002, 123 (03) :719-727

[5]

Fung SK, 2004, ANTIVIR THER, V9, P1013

[6] Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B [J].

Fung, SK ;

Wong, F ;

Hussain, M ;

Lok, ASF .

JOURNAL OF VIRAL HEPATITIS, 2004, 11 (05) :432-438

[7] Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B [J].

Hadziyannis, SJ ;

Tassopoulos, NC ;

Heathcote, EJ ;

Chang, TT ;

Kitis, G ;

Rizzetto, M ;

Marcellin, P ;

Lim, SG ;

Goodman, Z ;

Wulfsohn, MS ;

Xiong, S ;

Fry, J ;

Brosgart, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :800-807

[8] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B [J].

Hadziyannis, SJ ;

Tassopoulos, NC ;

Heathcote, EJ ;

Chang, TT ;

Kitis, G ;

Rizzetto, M ;

Marcellin, P ;

Lim, SG ;

Goodman, Z ;

Ma, J ;

Arterburn, S ;

Xiong, S ;

Currie, G ;

Brosgart, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2673-2681

[9] Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy [J].

Lau, GKK ;

Yiu, HHY ;

Fong, DYT ;

Cheng, HC ;

Au, WY ;

Lai, LSF ;

Cheung, M ;

Zhang, HY ;

Lie, A ;

Ngan, R ;

Liang, R .

GASTROENTEROLOGY, 2003, 125 (06) :1742-1749

[10] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B [J].

Lau, GKK ;

Piratvisuth, T ;

Luo, KX ;

Marcellin, P ;

Thongsawat, S ;

Cooksley, G ;

Gane, E ;

Fried, MW ;

Chow, WC ;

Paik, SW ;

Chang, WY ;

Berg, T ;

Flisiak, R ;

McCloud, P ;

Pluck, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2682-2695

← 1 2 →